Buserelin
- Generic Name
- Buserelin
- Brand Names
- Suprefact
- Drug Type
- Small Molecule
- Chemical Formula
- C60H86N16O13
- CAS Number
- 57982-77-1
- Unique Ingredient Identifier
- PXW8U3YXDV
Overview
Buserelin is a synthetic peptide analog of the luteinizing hormone-releasing hormone (LHRH) agonist, which stimulates the pituitary gland's gonadotrophin-releasing hormone receptor (GnRHR). It is used in prostate cancer treatment.
Background
Buserelin is a synthetic peptide analog of the luteinizing hormone-releasing hormone (LHRH) agonist, which stimulates the pituitary gland's gonadotrophin-releasing hormone receptor (GnRHR). It is used in prostate cancer treatment.
Indication
Buserelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction.
Associated Conditions
- Endometriosis
- Stage D2 Prostatic carcinoma
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.